Reuters exclusively reports Teva Pharm unlikely to reach deals to co-produce vaccines

Reuters exclusively reported that Israel’s Teva Pharmaceutical Industries is not likely to reach deals with COVID vaccine makers to co-produce the vaccines although discussions are still ongoing. Chief executive Kare Schultz told Reuters that Teva — the world’s largest generic drugmaker — offered to co-produce the vaccines in both Israel and Europe, where the company has capacity, to help with global supply. “But we’ve not been able to reach a firm agreement with any company,” he said.